Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors

  • Kirk L. Stevens
  • , Michael J. Reno
  • , Jennifer B. Alberti
  • , Daniel J. Price
  • , Laurie S. Kane-Carson
  • , Victoria B. Knick
  • , Lisa M. Shewchuk
  • , Anne M. Hassell
  • , James M. Veal
  • , Stephen T. Davis
  • , Robert J. Griffin
  • , Michael R. Peel

Research output: Contribution to journalArticlepeer-review

35 Scopus citations

Abstract

A novel series of pyrazolo[1,5-b]pyridazines have been synthesized and identified as cyclin dependant kinase inhibitors potentially useful for the treatment of solid tumors. Modification of the hinge-binding amine or the C(2)- and C(6)-substitutions on the pyrazolopyridazine core provided potent inhibitors of CDK4 and demonstrated enzyme selectivity against VEGFR-2 and GSK3β.

Original languageEnglish
Pages (from-to)5758-5762
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Volume18
Issue number21
DOIs
StatePublished - Nov 1 2008

Keywords

  • CDK2
  • CDK4
  • Cancer
  • Cyclin-dependant kinase inhibitor
  • GSK3β
  • Pyrazolo[1,5-b] pyridazine
  • VEGFR-2

Fingerprint

Dive into the research topics of 'Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors'. Together they form a unique fingerprint.

Cite this